Xu J, Wang B-Y, Yu S-H, Chen S-J, Yang S-S, Liu R, Chen L-J, Hou J, Chen Z, Zhao W-H, et al. Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial. J Hematol Oncol. 2024;17(1):23.